Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

Blood Cancer Journal

Volumn 4, Issue 3, 2014, Pages

  Ng, O H ^a   Erbilgin, Y ^a   Firtina, S ^a   Celkan, T ^a   Karakas, Z ^b   Aydogan, G ^c   Turkkan, E ^d   Yildirmak, Y ^e   Timur, C ^f   Zengin, E ^g   Van Dongen, J J M ^h   Staal, F J T ^h,i   Ozbek, U ^a   Sayitoglu, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Istanbul Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

^d OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^e SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f Medeniyet University   (Turkey)

^g KOCAELI UNIVERSITY   (Turkey)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN2; BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; NOTCH1 RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER SURVIVAL; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENE PROBE; GENE SILENCING; GENE TARGETING; GENETIC ALGORITHM; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA; LEUKOCYTE COUNT; LEUKOMOGENESIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MUTATION RATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; THYMOCYTE; UPREGULATION; WNT SIGNALING PATHWAY;

EID: 84901854195     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.12     Document Type: Article

References (45)

1. Staal FJ, Langerak AW. Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia. Haematologica 2008; 93: 493-497.
2. Weng AP, Lau A. Notch signaling in T-cell acute lymphoblastic leukemia. Future Oncol 2005; 1: 511-519.
3. Chien AJ, Conrad WH, Moon RT. A Wnt survival guide: from flies to human disease. J Invest Dermatol 2009; 129: 1614-1627.
4. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 2005; 5: 21-30.
5. Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006; 281: 22429-22433.
6. Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol 2004; 48: 477-487.
7. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
8. Weerkamp F, Baert MR, Naber BA, Koster EE, de Haas EF, Atkuri KR et al. Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. Proc Natl Acad Sci USA 2006; 103: 3322-3326.
9. Staal FJ, Weerkamp F, Baert MR, van den Burg CM, van Noort M, de Haas EF et al. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. J Immunol 2004; 172: 1099-1108.
10. Dejmek J, Dejmek A, Safholm A, Sjolander A, Andersson T. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65: 9142-9146.
11. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 2006; 103: 5454-5459.
12. Yang X, Chen MW, Terry S, Vacherot F, Bemis DL, Capodice J et al. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene 2006; 25: 4256.
13. Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB, ten Berge D, Nusse R et al. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 2008; 68: 6969-6977.
14. Guo Z, Dose M, Kovalovsky D, Chang R, O'Neil J, Look AT et al. Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 2007; 109: 5463-5472.
15. Tiemessen MM, Baert MR, Schonewille T, Brugman MH, Famili F, Salvatori DC et al. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas. PLoS Biol 2012; 10: e1001430.
16. Erbilgin Y, Ng OH, Mavi N, Ozbek U, Sayitoglu M. Genetic alterations in members of the Wnt pathway in acute leukemia. Leuk Lymphoma 2011; 53: 508-510.
17. Staal FJ, Cario G, Cazzaniga G, Haferlach T, Heuser M, Hofmann WK et al. Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia 2006; 20: 1385-1392.
18. Erbilgin Y, Sayitoglu M, Hatirnaz O, Dogru O, Akcay A, Tuysuz G et al. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Dis Markers 2010; 28: 353-360.
19. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
21. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-array tools. Cancer Inform 2007; 3: 11-17.
22. de Ridder D, Staal FJ, van Dongen JJ, Reinders MJ. Maximum significance clustering of oligonucleotide microarrays. Bioinformatics 2006; 22: 326-331.
23. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
25. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000.
26. Naishiro Y, Yamada T, Takaoka AS, Hayashi R, Hasegawa F, Imai K et al. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res 2001; 61: 2751-2758.
27. Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 1999; 19: 5696-5706.
28. Staal FJ, Noort Mv M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 2002; 3: 63-68.
29. Tong JH, To KF, Ng EK, Lau JY, Lee TL, Lo KW et al. Somatic beta-catenin mutation in gastric carcinoma-an infrequent event that is not specific for microsatellite instability. Cancer Lett 2001; 163: 125-130.
30. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1992; 52: 6696-6698.
31. Yamada Y, Oyama T, Hirose Y, Hara A, Sugie S, Yoshida K et al. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis 2003; 24: 91-97.
32. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1653: 1-24.
33. Asally M, Yoneda Y. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). Exp Cell Res 2005; 308: 357-363.
34. Hovanes K, Li TW, Waterman ML. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 2000; 28: 1994-2003.
35. Schilham MW, Wilson A, Moerer P, Benaissa-Trouw BJ, Cumano A, Clevers HC. Critical involvement of Tcf-1 in expansion of thymocytes. J Immunol 1998; 161: 3984-3991.
36. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 2006; 7: 1048-1056.
37. Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol 2001; 193: 95-101.
38. Saegusa M, Hashimura M, Yoshida T, Okayasu I. beta-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 2001; 84: 209-217.
39. Kuhnl A, Gokbuget N, Kaiser M, Schlee C, Stroux A, Burmeister T et al. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 118: 6362-6367.
40. Metzeler KH, Heilmeier B, Edmaier KE, Rawat VP, Dufour A, Dohner K et al. High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Blood 120: 2118-2126.
41. Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S et al. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood 2010; 115: 2845-2851.
42. Klein EA, Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 2008; 121(Pt 23): 3853-3857.
43. Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S et al. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 2002; 277: 21657-21665.
44. Sayitoglu M, Erbilgin Y, Ng Hatirnaz O, Yildiz I, Celkan T, Anak S et al. Upregulation of T-cell specific transcription factor expression in pediatric T-ALL. Turk J Hematol 2012; 29: 325-333.
45. Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006; 15: 701-707.